Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?

Han D, Zager JS, Yu D, Zhao X, Walls B, Marzban SS, Rao NG, Sondak VK, Messina JL.

Ann Surg Oncol. 2013 Jul;20(7):2345-51. doi: 10.1245/s10434-013-2883-z. Epub 2013 Feb 7.

2.

Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.

Broer PN, Walker ME, Goldberg C, Buonocore S, Braddock DT, Lazova R, Narayan D, Ariyan S.

Eur J Surg Oncol. 2013 Jul;39(7):681-5. doi: 10.1016/j.ejso.2013.02.025. Epub 2013 Mar 22.

PMID:
23522951
3.

Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.

Han D, Yu D, Zhao X, Marzban SS, Messina JL, Gonzalez RJ, Cruse CW, Sarnaik AA, Puleo C, Sondak VK, Zager JS.

Ann Surg Oncol. 2012 Oct;19(11):3335-42. doi: 10.1245/s10434-012-2469-1. Epub 2012 Jul 6.

4.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
5.

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP.

J Clin Oncol. 2013 Dec 10;31(35):4387-93. doi: 10.1200/JCO.2013.50.1114. Epub 2013 Nov 4.

PMID:
24190111
6.

Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.

Yamamoto M, Fisher KJ, Wong JY, Koscso JM, Konstantinovic MA, Govsyeyev N, Messina JL, Sarnaik AA, Cruse CW, Gonzalez RJ, Sondak VK, Zager JS.

Cancer. 2015 May 15;121(10):1628-36. doi: 10.1002/cncr.29239. Epub 2015 Feb 11.

7.

Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.

Ellis MC, Weerasinghe R, Corless CL, Vetto JT.

Am J Surg. 2010 May;199(5):663-8. doi: 10.1016/j.amjsurg.2010.01.019.

PMID:
20466113
8.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Jul;41(7):823-9. doi: 10.1016/j.ejso.2015.02.005. Epub 2015 Mar 11.

PMID:
25800935
9.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
10.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
11.

Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.

Gyorki DE, Boyle JO, Ganly I, Morris L, Shaha AR, Singh B, Wong RJ, Shah JP, Busam K, Kraus D, Coit DG, Patel S.

Eur J Surg Oncol. 2014 Mar;40(3):305-10. doi: 10.1016/j.ejso.2013.11.017. Epub 2013 Dec 13.

PMID:
24361245
12.
13.

Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas.

Patuzzo R, Maurichi A, Camerini T, Gallino G, Ruggeri R, Baffa G, Mattavelli I, Tinti MC, Crippa F, Moglia D, Tolomio E, Maccauro M, Santinami M.

J Surg Res. 2014 Apr;187(2):518-24. doi: 10.1016/j.jss.2013.10.037. Epub 2013 Oct 23.

PMID:
24252855
14.

The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.

Bello DM, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):938-945. Epub 2016 Aug 15.

PMID:
27527717
15.

Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.

Yokota K, Sawada M, Matsumoto T, Hasegawa Y, Kono M, Akiyama M.

J Dermatol Sci. 2015 May;78(2):101-7. doi: 10.1016/j.jdermsci.2015.02.011. Epub 2015 Feb 25.

PMID:
25771166
16.

A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.

Wat H, Senthilselvan A, Salopek TG.

J Am Acad Dermatol. 2016 Jan;74(1):94-101. doi: 10.1016/j.jaad.2015.09.014. Epub 2015 Nov 2.

PMID:
26542815
17.

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.

Br J Cancer. 2005 Feb 28;92(4):662-7.

18.

Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.

Gambichler T, Scholl L, Bechara FG, Stockfleth E, Stücker M.

Eur J Surg Oncol. 2016 Sep;42(9):1420-6. doi: 10.1016/j.ejso.2016.03.038. Epub 2016 Apr 19.

PMID:
27160354
19.

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.

Eur J Surg Oncol. 2008 Jan;34(1):82-8. Epub 2007 Mar 13.

PMID:
17360144
20.

Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.

Fairbairn NG, Orfaniotis G, Butterworth M.

J Plast Reconstr Aesthet Surg. 2012 Oct;65(10):1396-402. doi: 10.1016/j.bjps.2012.04.019. Epub 2012 May 1.

PMID:
22552263

Supplemental Content

Support Center